Our findings indicate that CBX4 is a promising target that may be used as a biomarker for early diagnosis and that inhibition of CBX4 could be a potential therapeutic target to inhibit the proliferation and metastasis in lung cancer. Here, CBX4 is linked to lung carcinoma.